Skip to main content
. 2017 Sep 26;32(1):1229–1239. doi: 10.1080/14756366.2017.1368504

Figure 1.

Figure 1.

Structures of erlotinib, gefitinib, reported compounds AD, and designed quinazoline derivatives EH as antitumour agents.